We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current REGN market cap is 98.8B. The company's latest EPS is USD 36.0198 and P/E is 24.99.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 3.42B | 3.16B | 3.16B | 3.36B | 3.43B |
Operating Income | 1.05B | 946.7M | 1.02B | 1.11B | 972.9M |
Net Income | 1.2B | 817.8M | 968.4M | 1.01B | 1.16B |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 7.86B | 8.78B | 16.12B | 12.26B | 13.12B |
Operating Income | 2.21B | 3.58B | 8.95B | 4.74B | 4.05B |
Net Income | 2.12B | 3.51B | 8.08B | 4.34B | 3.95B |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 29.21B | 30.06B | 30.66B | 32.16B | 33.08B |
Total Liabilities | 6.55B | 6.56B | 6.64B | 7.26B | 7.11B |
Total Equity | 22.66B | 23.5B | 24.02B | 24.9B | 25.97B |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 14.81B | 17.16B | 25.43B | 29.21B | 33.08B |
Total Liabilities | 3.72B | 6.14B | 6.67B | 6.55B | 7.11B |
Total Equity | 11.09B | 11.03B | 18.77B | 22.66B | 25.97B |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 5.01B | 1.37B | 2.39B | 3.5B | 4.59B |
Investing | -3.78B | -235.7M | -2.62B | -3.12B | -3.19B |
Financing | -1.01B | -322.5M | -936.7M | -1.34B | -1.79B |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 2.43B | 2.62B | 7.08B | 5.01B | 4.59B |
Investing | -2.03B | -70.6M | -5.38B | -3.78B | -3.19B |
Financing | -252.1M | -1.97B | -1.01B | -1.01B | -1.79B |
Market Cap | 98.8B |
Price to Earnings Ratio | 24.99 |
Price to Sales Ratio | 7.53 |
Price to Cash Ratio | 36.19 |
Price to Book Ratio | 3.8 |
Dividend Yield | - |
Shares Outstanding | 109.76M |
Average Volume (1 week) | 470.92k |
Average Volume (1 Month) | 444.55k |
52 Week Change | 12.46% |
52 Week High | 998.325 |
52 Week Low | 684.805 |
Spread (Intraday) | 73.89 (7.67%) |
Company Name | Regeneron Pharmaceuticals Inc |
Address |
28 liberty street new york, new york 10005 |
Website | https://www.regeneron.com |
Industry | health care diversified (H) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions